FDA Drugs recall ·
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only… recall
- Recall number
- D-0306-2026
- Date
- (initiated January 21, 2026)
- Company / brand
- Unichem Pharmaceuticals USA Inc.
1 Tower Center Blvd Ste 2200, East Brunswick, NJ, United States - Category
- Drugs › Class III
- Classification
- Class III
- Status
- Ongoing
- Units affected
- 60,000 tablets
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
Why was it recalled?
Tablets/Capsules Imprinted with Wrong ID
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot # GDSH25006, Exp Date: 08/2027
Distribution
Nationwide
What does Class III mean?
Class III means use of or exposure to the product is not likely to cause adverse health consequences (for example, a labeling violation).
Source: FDA (drugs), recall D-0306-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.